Population-based incidence of human metapneumovirus infection among hospitalized children
- PMID: 20446850
- PMCID: PMC2873123
- DOI: 10.1086/652782
Population-based incidence of human metapneumovirus infection among hospitalized children
Abstract
Background: Human metapneumovirus (HMPV) is a leading cause of acute respiratory illness (ARI) in children. Population-based incidence rates and comprehensive clinical characterizations of disease have not been established.
Methods: We conducted population-based prospective surveillance for 2 years in 2 US counties of HMPV infection among children <5 years old who were hospitalized with ARI or fever. Nasal and throat specimens obtained with swabs were tested for HMPV by real-time reverse-transcription polymerase chain reaction and genotyped.
Results: Forty-two (3.8%) of 1104 children tested positive for HMPV. The overall annual rate of HMPV-associated hospitalizations per 1000 children <5 years old was 1.2 (95% confidence interval [CI], 0.9-1.6). This rate was highest among infants 0-5 months old (4.9 per 1000 [95% CI, 2.9-7.2]), followed by children 6-11 months old (2.9 per 1000 [95% CI, 1.4-4.7]). The annual rate of hospitalization for HMPV infection was less than that for respiratory syncytial virus infection but similar to that for influenza and parainfluenza virus 3 infection in all age groups. The mean age of children hospitalized with HMPV infection was 6 months. Bronchiolitis, pneumonia, and asthma were the most common diagnoses among children with HMPV infection. All 4 HMPV subgroups were detected during both years at both sites. HPMV infection was most prominent from March through May.
Conclusion: HMPV was detected in 3.8% of children hospitalized with ARI or fever, with a population incidence similar to that of influenza virus and parainfluenza virus 3.
Conflict of interest statement
Potential conflicts of interest: J.V.W. has served as a consultant for MedImmune and Novartis. K.M.E. receives research funding from Sanofi-Pasteur, Wyeth, Novartis, and CSL. G.A.W. has served as a consultant for MedImmune. M.R.G. has received research funding from MedImmune and Merck. C.B.H. has served as a consultant for and received research support from MedImmune. J.E.C. has served as a consultant for Anaptys, Immunobiosciences, Mapp, MedImmune, and Novartis and has received research support from MedImmune, Mapp, Alnylam, and Sanofi-Pasteur. C.K.W., C.-F.Y., D.S., D.Y., and R.R.S. were employees of MedImmune at the time of this study. All other authors report no potential conflicts.
Figures






Comment in
-
Human metapneumovirus infection as an emerging pathogen causing acute respiratory distress syndrome.J Infect Dis. 2011 Jan 15;203(2):294-5; author reply 296. doi: 10.1093/infdis/jiq045. J Infect Dis. 2011. PMID: 21288832 Free PMC article. No abstract available.
Similar articles
-
Human metapneumovirus infection in young children hospitalized with acute respiratory tract disease: virologic and clinical features.Pediatr Infect Dis J. 2008 May;27(5):406-12. doi: 10.1097/INF.0b013e318162a164. Pediatr Infect Dis J. 2008. PMID: 18382388
-
Human metapneumovirus in hospitalized children less than 5 years of age in Pakistan.J Med Virol. 2018 Jun;90(6):1027-1032. doi: 10.1002/jmv.25044. Epub 2018 Mar 12. J Med Virol. 2018. PMID: 29424432
-
Comparative epidemiology of human metapneumovirus- and respiratory syncytial virus-associated hospitalizations in Guatemala.Influenza Other Respir Viruses. 2014 Jul;8(4):414-21. doi: 10.1111/irv.12251. Epub 2014 Apr 25. Influenza Other Respir Viruses. 2014. PMID: 24761765 Free PMC article.
-
Human metapneumovirus in Jordan: prevalence and clinical symptoms in hospitalized pediatric patients and molecular virus characterization.Diagn Microbiol Infect Dis. 2012 Nov;74(3):288-91. doi: 10.1016/j.diagmicrobio.2012.07.004. Epub 2012 Sep 6. Diagn Microbiol Infect Dis. 2012. PMID: 22959817
-
Human Metapneumovirus: A Review of Its Epidemiology, Clinical Features, Public Health Implications and Treatment Options.Rev Med Virol. 2025 Jul;35(4):e70043. doi: 10.1002/rmv.70043. Rev Med Virol. 2025. PMID: 40462238 Review.
Cited by
-
Viral etiology and epidemiology of pediatric patients hospitalized for acute respiratory tract infections in Macao: a retrospective study from 2014 to 2017.BMC Infect Dis. 2021 Mar 26;21(1):306. doi: 10.1186/s12879-021-05996-x. BMC Infect Dis. 2021. PMID: 33771128 Free PMC article.
-
Pediatric burden and seasonality of human metapneumovirus over 5 years in Managua, Nicaragua.Influenza Other Respir Viruses. 2022 Nov;16(6):1112-1121. doi: 10.1111/irv.13034. Epub 2022 Aug 14. Influenza Other Respir Viruses. 2022. PMID: 35965382 Free PMC article.
-
Comparing Human Metapneumovirus and Respiratory Syncytial Virus: Viral Co-Detections, Genotypes and Risk Factors for Severe Disease.PLoS One. 2017 Jan 17;12(1):e0170200. doi: 10.1371/journal.pone.0170200. eCollection 2017. PLoS One. 2017. PMID: 28095451 Free PMC article.
-
Incidence, Morbidity, and Costs of Human Metapneumovirus Infection in Hospitalized Children.J Pediatric Infect Dis Soc. 2016 Sep;5(3):303-11. doi: 10.1093/jpids/piv027. Epub 2015 May 20. J Pediatric Infect Dis Soc. 2016. PMID: 26407261 Free PMC article.
-
Human metapneumovirus in the preterm neonate: current perspectives.Res Rep Neonatol. 2016;6:41-49. doi: 10.2147/RRN.S76270. Epub 2016 Jul 28. Res Rep Neonatol. 2016. PMID: 27891060 Free PMC article.
References
-
- McAdam AJ, Hasenbein ME, Feldman HA, et al. Human metapneumovirus in children tested at a tertiary-care hospital. J Infect Dis. 2004;190:20–26. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical